News | November 06, 2007

faCTor64 Uses 64-Slice CTA to Study Early Detection of CAD

November 7, 2007 - Toshiba America Medical Systems Inc. announced the launch of a new study, faCTor64, the Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, designed to assess an asymptomatic diabetic population at higher risk for CHD using cardiac CT angiography.

The faCTor64 study will use Toshiba’s Aquilion 64-slice CT system to capture obstructive and non-obstructive, or sub-clinical, coronary heart disease data to determine the best way to treat diabetic patients.

The study will be performed in conjunction with Intermountain Healthcare, a community-owned system of nonprofit hospitals and clinics based in Salt Lake City, UT, that provides medical care to residents of Utah and Idaho. More than 1,000 patients from Utah, women older than 55 years old and men older than 50 years old, will be enrolled in the faCTor64 study using Intermountain Healthcare’s diabetes registry of 30,000 patients, who have already received best-practice diabetic care. Intermountain, known for its quality initiatives, has one of the largest diabetic databases in the country.

“Patients with diabetes have two- to four-times greater risk of cardiovascular disease than non-diabetic patients,” explained Donald Lappe, M.D., FACC, chief of cardiology at Intermountain Medical Center in Salt Lake City and medical director of the Intermountain Healthcare Cardiovascular Clinical Program. “This, coupled with the fact that cardiovascular death is the most common cause of mortality among Type 2 diabetics, emphasizes the importance of the faCTor64 study. The ability to detect CHD in at-risk, asymptomatic patients will have a significant impact on the ability to improve their cardiac conditions and will help save lives.”

“We believe the results of faCTor64 will improve the diagnosis and treatment of diabetes patients, who are more likely to develop CHD,” said Toshihiro Rifu, senior fellow, Toshiba Medical Systems Corp.

The faCTor64 procedure is based on Toshiba’s CorE 64 study and will be conducted in partnership with Johns Hopkins University. Enrollment for the study has already begun. Intermountain Healthcare Center is using its five Toshiba Aquilion 64-slice CT systems to diagnose patients in the study.

For more information: www.medical.toshiba.com

Related Content

A comparison of CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockages and the correspending FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention.

A comparison of a CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockage and the corresponding FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention. Image courtesy of Kavitha Chinnaiyan, William Beaumont Hospital.

Feature | CT Angiography (CTA) | July 23, 2018 | Dave Fornell, Editor
The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of Cardiov
Videos | CT Angiography (CTA) | July 19, 2018
Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine,
Videos | CT Angiography (CTA) | July 18, 2018
A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino,
Videos | CT Angiography (CTA) | July 17, 2018
A discussion with Todd Villines, M.D., FACC, FAHA, FSCCT, cardiologist, Georgetown Medical Center, and president of t
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | CT Angiography (CTA) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
iSchemaView Receives FDA Clearance for Rapid CTA
Technology | CT Angiography (CTA) | May 01, 2018
Cerebrovascular imaging analysis company iSchemaView received final clearance from the U.S. Food and Drug...
The use of metal artifact reduction software on this CCTA (CTA) cardiac CT from an Canon, Toshiba, Aquilion Precision, allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

The use of metal artifact reduction software on this Aquilion Precision image allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

Feature | CT Angiography (CTA) | April 26, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology.
Siemens Healthineers, Florida Hospital Collaborate to Improve Healthcare Outcomes
News | CT Angiography (CTA) | January 23, 2018
January 23, 2018 – Siemens Healthineers and Florida Hospital, part of Adventist Health System, have announced a multi
Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
Overlay Init